Dendritic cell vaccination for hepatocellular carcinoma.

Benzer Materyaller

• A phase I/II dendritic cell (DC) immunotherapy trial for hepatocellular carcinoma (HC)
  Yazar:: Midgley, R, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma
  Yazar:: Midgley, R, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
  Yazar:: Palmer, D, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Dendritic Cell-Based Vaccines Positively Impact Natural Killer and Regulatory T Cells in Hepatocellular Carcinoma Patients
  Yazar:: Sarah M. Bray, ve diğerleri
  Baskı/Yayın Bilgisi: (2011-01-01)
• Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
  Yazar:: Wenya Li, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-09-01)